SOPHiA GENETICS SA (SOPH) Misses Q4 EPS by 15c, Misses on Revenue; Offers FY24 Revenue Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. LRCX
7. LVS
8. CSX
9. QGEN
10. KNX

Go back to SOPHiA GENETICS SA (SOPH) Misses Q4 EPS by 15c, Misses on Revenue; Offers FY24 Revenue Guidance

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results

March 5, 2024 6:45 AM EST

BOSTON and ROLLE, Switzerland, March 05, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today reported financial results for its fourth quarter and fiscal year ended December 31, 2023.

Fourth Quarter 2023 Financial Highlights

Revenue grew 27% year-over-year to $17.0 million; Constant currency revenue excluding COVID-related revenue also grew 27% year-over-yearGross margins were 70% on a reported basis and 73% on an adjusted basisOperating loss was $18.9 million on a reported basis and $13.3 million on an adjusted basisChange in cash and cash equivalents and... More